Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026)
Maze Therapeutics (MAZE) reported Asset Utilization Ratio of 0.05 for Q1 2026, up 110.4% on a YoY basis from 0.02 in Q1 2025, and up 111.65% sequentially from 0.42 in Q3 2025.
Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 2 years of Asset Utilization Ratio data on file, last reported at 0.05 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | 0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.05 |
| Sep 30, 2025 | -0.42 |
| Jun 30, 2025 | -0.47 |
| Mar 31, 2025 | -0.47 |